06/05/2026
The new issue of Retina Today looks to the future of AMD care through a lens of exploration, innovation, and scientific persistence.
From emerging approaches in wet AMD, including tyrosine kinase inhibitors and gene therapy, to evolving strategies for concurrent GA and neovascular disease, this issue examines how the treatment landscape continues to expand.
Contributors also review step therapy advocacy, imaging biomarkers for GA progression, photobiomodulation for intermediate AMD, diet and long-term AMD outcomes, and landmark clinical trial data that continue to shape practice.
As novel mechanisms of action and delivery systems move closer to clinical reality, retina specialists are navigating an increasingly complex decision tree. The path forward may require patience, precision, and repeated course corrections, but each advance brings the field closer to preserving vision in more patients.
Read now at RetinaToday.com